Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | FOS | P01100 | 2/20 | 0.38 |
| ▸ | JUN | P05412 | 2/20 | 0.38 |
| ▸ | F13A1 | P00488 | 3/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | CSF3R | Q99062 | 1/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.36 |
| ▸ | PTGFR | P43088 | 1/20 | 0.36 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.36 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26206096 | 0.90 | MEN1 (0.38) | ALDH1A1PPARG | |
| SCHEMBL26206478 | 0.88 | FOS (0.38) | FOSJUNF13A1PLA2G2ACSF3R | |
| SCHEMBL26206483 | 0.87 | FFAR4 (0.39) | FFAR4FFAR1FOSJUNF13A1 | |
| SCHEMBL26206459 | 0.82 | FFAR1 (0.47) | FFAR1 | |
| SCHEMBL22525554 | 0.81 | AAK1 (0.41) | FFAR4FFAR1PLA2G2ATBXA2RPTGER1 | |
| SCHEMBL30169427 | 0.81 | AAK1 (0.41) | FFAR4FFAR1PLA2G2ATBXA2RPTGER1 | |
| SCHEMBL26206371 | 0.81 | S1PR1 (0.39) | FFAR4FFAR1PPARG | |
| SCHEMBL25123368 | 0.81 | GPR88 (0.39) | KDM4EALDH1A1TSHR | |
| SCHEMBL26206374 | 0.81 | PPARA (0.51) | FFAR1FOSJUNPLA2G2ACSF3R | |
| SCHEMBL26206373 | 0.80 | TBXA2R (0.37) | FFAR4CSF3RTBXA2RPTGER1PTGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11746120-B2 | Stat degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2023-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746120-B2 | Stat degraders and uses thereof | STAT4, STAT1, STAT3 | FFAR4 3503/4885FFAR1 4114/4885FOS 3232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.